These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3791364)

  • 21. Treatment of tinea pedis with a single pulse of itraconazole.
    Bonifaz A; Saúl A
    Eur J Dermatol; 2002; 12(2):157-9. PubMed ID: 11872413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fungicidal activity plus reservoir effect allow short treatment courses with terbinafine in tinea pedis.
    Schäfer-Korting M; Schoellmann C; Korting HC
    Skin Pharmacol Physiol; 2008; 21(4):203-10. PubMed ID: 18509254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost of topical products for tinea pedis.
    Med Lett Drugs Ther; 2010 May; 52(1337):35-6. PubMed ID: 20431521
    [No Abstract]   [Full Text] [Related]  

  • 24. Short-duration therapy for superficial tinea infections.
    Elewski BE
    Am Fam Physician; 1994 May; 49(6):1349-50. PubMed ID: 8172031
    [No Abstract]   [Full Text] [Related]  

  • 25. Effectiveness and tolerability of a standardized phytodrug derived from Solanum chrysotrichum on Tinea pedis: a controlled and randomized clinical trial.
    Herrera-Arellano A; Rodríguez-Soberanes A; de los Angeles Martínez-Rivera M; Martínez-Cruz E; Zamilpa A; Alvarez L; Tortoriello J
    Planta Med; 2003 May; 69(5):390-5. PubMed ID: 12802717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Naftifine gel in the treatment of tinea pedis: two double-blind, multicenter studies. Naftifine Gel Study Group.
    Cutis; 1991 Jul; 48(1):85-8. PubMed ID: 1868748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic investigation of oral itraconazole in stratum corneum level of tinea pedis.
    Morimoto K; Tanuma H; Kikuchi I; Kusunoki T; Kawana S
    Mycoses; 2004 Apr; 47(3-4):104-14. PubMed ID: 15078426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Phase 2, Controlled, Dose-Ranging Study of SB208, an Investigational Topical Nitric Oxide-Releasing Drug, for the Treatment of Tinea Pedis.
    Elewski BE; Kircik LH; Stasko N; De Leon E; Enloe C; Durham T; Maeda-Chubachi T
    J Drugs Dermatol; 2018 Aug; 17(8):888-893. PubMed ID: 30124729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapeutic efficacy of a topical antifungal solution preparation formulated with pyrrolnitrin and clotrimazole in combination (Pyroace W) in guinea pig model of tinea pedis].
    Uchida K; Ymaguchi H
    Jpn J Antibiot; 1999 Jan; 52(1):68-74. PubMed ID: 10202689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What defines the quality of patient care in tinea pedis?
    Mistik S; Ferahbas A; Koc AN; Ayangil D; Ozturk A
    J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):158-65. PubMed ID: 16441623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of onychomycosis and tinea pedis with intermittent itraconazole therapy.
    Del Rosso JQ
    J Am Osteopath Assoc; 1996 Oct; 96(10):607-9. PubMed ID: 8936929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative efficacy of topical 1% butenafine and 1% clotrimazole in tinea cruris and tinea corporis: a randomized, double-blind trial.
    Singal A; Pandhi D; Agrawal S; Das S
    J Dermatolog Treat; 2005; 16(5-6):331-5. PubMed ID: 16428155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [1% tioconazole powder in the treatment of dermatomycoses].
    Tulli A; Leone E; De Simone C
    Clin Ter; 1988 Sep; 126(6):417-20. PubMed ID: 2974403
    [No Abstract]   [Full Text] [Related]  

  • 34. Econazole Nitrate Foam 1% Improves the Itch of Tinea Pedis.
    Fleischer AB; Raymond I
    J Drugs Dermatol; 2016 Sep; 15(9):1111-4. PubMed ID: 27602974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brazilian green propolis extracts improve Tinea pedis interdigitalis and Tinea corporis.
    Ngatu NR; Saruta T; Hirota R; Eitoku M; Luzitu NS; Muzembo BA; Matsui T; Suganuma N
    J Altern Complement Med; 2012 Jan; 18(1):8-9. PubMed ID: 22229708
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatments of tinea pedis.
    Gupta AK; Chow M; Daniel CR; Aly R
    Dermatol Clin; 2003 Jul; 21(3):431-62. PubMed ID: 12956197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Butenafine, a fungicidal benzylamine derivative, used once daily for the treatment of interdigital tinea pedis.
    Reyes BA; Beutner KR; Cullen SI; Rosen T; Shupack JL; Weinstein MB
    Int J Dermatol; 1998 Jun; 37(6):450-3. PubMed ID: 9646136
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of over-the-counter agents for tinea pedis.
    Tschen EH; Becker LE; Ulrich JA; Hoge WH; Smith EB
    Cutis; 1979 May; 23(5):696-8. PubMed ID: 378561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Bay B 5097 (solution) in tinea pedis].
    Moreno Collado C; Avila Varguez JJ; Vargas de Roldan M
    Prensa Med Mex; 1975; 40(7-8):259-66. PubMed ID: 1219701
    [No Abstract]   [Full Text] [Related]  

  • 40. Statistically designed nonionic surfactant vesicles for dermal delivery of itraconazole: characterization and in vivo evaluation using a standardized Tinea pedis infection model.
    Kumar N; Goindi S
    Int J Pharm; 2014 Sep; 472(1-2):224-40. PubMed ID: 24954723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.